UMB Financial (UMBF)
(Delayed Data from NSDQ)
$78.53 USD
-0.89 (-1.12%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $78.44 -0.09 (-0.11%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth C Momentum D VGM
Price, Consensus and EPS Surprise
UMBF 78.53 -0.89(-1.12%)
Will UMBF be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for UMBF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for UMBF
Why Is UMB (UMBF) Down 3.4% Since Last Earnings Report?
4 Reasons to Add UMB Financial (UMBF) to Your Stock Portfolio
UMBF: What are Zacks experts saying now?
Zacks Private Portfolio Services
UMB Financial (UMBF) Q4 Earnings Beat Estimates, Costs Rise
UMB (UMBF) Reports Q4 Earnings: What Key Metrics Have to Say
UMB Financial (UMBF) Tops Q4 Earnings and Revenue Estimates
Other News for UMBF
UMB Financial Corp's Dividend Analysis
UMB Financial initiated with neutral view at Barclays
Ex-Dividend Reminder: UMB Financial, Old Republic International and Healthstream
Dividend Champion, Contender, And Challenger Highlights: Week Of March 3
Gator Capital Management Q4 2023 Investor Letter